首页> 外文期刊>American Journal of Translational Research >LncRNA GAS5 expression in non-small cell lung cancer tissues and its correlation with Ki67 and EGFR
【24h】

LncRNA GAS5 expression in non-small cell lung cancer tissues and its correlation with Ki67 and EGFR

机译:LNCRNA气体5在非小细胞肺癌组织中的表达及其与KI67和EGFR的相关性

获取原文
           

摘要

Objective: This research explored and analyzed LncRNA GAS5 expression in non-small cell lung cancer (NSCLC) tissues and its correlation with Ki67 and EGFR. Methods: A total of 130 samples of paraffin-embedded NSCLC tissues and para-cancerous normal tissues that were collected in the Department of Pathology from January 2014 to April 2016 were selected. The relative expression of LncRNA GAS5 and Ki67/EGFR in both NSCLC tissues and para-cancerous normal tissues were detected via RT-PCR and immunohistochemistry respectively. Subsequently, we analyzed the relative expression of LncRNA GAS5, the expression of Ki67/EGFR and its correlation with clinicopathological features and prognosis of patients, and studied the correlation between LncRNA GAS5 and Ki67/EGFR. Results: The relative expression of LncRNA GAS5 in NSCLC tissues was substantially less than that of the para-cancerous normal tissues ( P0.05 ). The positive expression rate of Ki67/EGFR in NSCLC tissues remarkably exceeded that in para-cancerous normal tissues ( P0.05 ). The relative expression of LncRNA GAS5 was correlated with the degree of tumor differentiation, TNM staging and lymph node metastasis ( P0.05 ). The positive expression rate of Ki67 and EGFR in NSCLC tissues was related to TNM stage and metastasis of lymph node ( P0.05 ). In addition, the survival of patients with high LncRNA GAS5 expression was obviously superior to those with low LncRNA GAS5 expression ( P0.05 ), patients with negative Ki67 had superior survival than those with positive Ki67 ( P0.05 ), and patients with negative EGFR had increased survival over those with positive EGFR ( P0.05 ). Moreover, the positive rates of Ki67 and EGFR in patients with low LncRNA GAS5 expressions were obviously higher than those with high LncRNA GAS5 expressions ( P0.05 ). The relative expression level of LncRNA GAS5 in NSCLC patients had a remarkably negative correlation with Ki67 and EGFR ( P0.05 ). Conclusion: The decrease in LncRNA GAS5 expression and the over-express of Ki67/EGFR occur in NSCLC tissues, the expressions of LncRNA GAS5, Ki67 and EGFR are connected with the progression, metastasis and prognosis of tumor; and LncRNA GAS5 is related to the expression of Ki67 and EGFR. These three factors are involved in the tumorigenesis and growth of the NSCLC process.
机译:目的:本研究探讨了非小细胞肺癌(NSCLC)组织中的LNCRNA气体5表达及其与Ki67和EGFR的相关性。方法:从2014年1月至2016年1月,共有130种石蜡嵌入式NSCLC组织和癌症嵌入式NSCLC组织和对癌性正常组织,于2016年1月至2016年4月收集。通过RT-PCR和免疫组织分别检测LNCRNA气体5和Ki67 / EGFR在NSCLC组织和癌癌正常组织中的相对表达。随后,我们分析了LNCRNA气体5的相对表达,Ki67 / EGFR的表达及其与患者的临床病理特征和预后的相关性,并研究了LNCRNA气体5和Ki67 / EGFR之间的相关性。结果:NSCLC组织中LNCRNA气体5的相对表达基本上小于对癌常规组织(P <0.05)的相对表达。在Para癌正常组织中显着超过NMSCLC组织中Ki67 / EGFR的阳性表达率(P <0.05)。 LNCRNA气体5的相对表达与肿瘤分化,TNM分期和淋巴结转移的程度相关(P <0.05)。 NSCLC组织中的KI67和EGFR的阳性表达率与淋巴结的TNM阶段和转移有关(P <0.05)。此外,高LNCRNA气体5表达患者的存活率明显优于LNCRNA气体5表达(P <0.05)的那些,阴性Ki67的患者具有优异的存活率,而不是阳性Ki67(P <0.05),以及负的患者EGFR增加了阳性EGFR的生存率(P <0.05)。此外,低LNCRNA气体5表达患者的KI67和EGFR的阳性率明显高于高LNCRNA气体5表达的阳性率(P <0.05)。 NSCLC患者中LNCRNA气体5的相对表达水平与Ki67和EGFR(P <0.05)具有显着的负相关性。结论:LNCRNA气体5的降低和Ki67 / EGFR的过度表达发生在NSCLC组织中,LNCRNA气体5,Ki67和EGFR的表达与肿瘤的进展,转移和预后连接;并且LNCRNA气体5与KI67和EGFR的表达有关。这三种因素参与了NSCLC过程的肿瘤发生和生长。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号